These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11008904)

  • 21. A case-control study of toenail selenium and cancer of the breast, colon, and prostate.
    Ghadirian P; Maisonneuve P; Perret C; Kennedy G; Boyle P; Krewski D; Lacroix A
    Cancer Detect Prev; 2000; 24(4):305-13. PubMed ID: 11059562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
    Weinstein SJ; Wright ME; Pietinen P; King I; Tan C; Taylor PR; Virtamo J; Albanes D
    J Natl Cancer Inst; 2005 Mar; 97(5):396-9. PubMed ID: 15741576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Height, urban-born and prostate cancer risk in Japanese men.
    Minami Y; Tochigi T; Kawamura S; Tateno H; Hoshi S; Nishino Y; Kuwahara M
    Jpn J Clin Oncol; 2008 Mar; 38(3):205-13. PubMed ID: 18272473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate.
    Comstock GW; Gordon GB; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):219-21. PubMed ID: 8318873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are men with low selenium levels at increased risk of prostate cancer?
    Brinkman M; Reulen RC; Kellen E; Buntinx F; Zeegers MP
    Eur J Cancer; 2006 Oct; 42(15):2463-71. PubMed ID: 16945521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5 alpha-reductase activity and prostate cancer: a case-control study using stored sera.
    Guess HA; Friedman GD; Sadler MC; Stanczyk FZ; Vogelman JH; Imperato-McGinley J; Lobo RA; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):21-4. PubMed ID: 8993793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selenium is inversely associated with bladder cancer risk: a report from the Belgian case-control study on bladder cancer.
    Kellen E; Zeegers M; Buntinx F
    Int J Urol; 2006 Sep; 13(9):1180-4. PubMed ID: 16984549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
    Kilkkinen A; Virtamo J; Virtanen MJ; Adlercreutz H; Albanes D; Pietinen P
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1209-12. PubMed ID: 14652283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer.
    Li H; Kantoff PW; Ma J; Stampfer MJ; George DJ
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1557-61. PubMed ID: 15941972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between coronary heart disease and cancers of the breast, prostate, and colon.
    Neugut AI; Rosenberg DJ; Ahsan H; Jacobson JS; Wahid N; Hagan M; Rahman MI; Khan ZR; Chen L; Pablos-Mendez A; Shea S
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):869-73. PubMed ID: 9796631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
    J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical history, body size, and cigarette smoking in relation to fatal prostate cancer.
    Weinmann S; Shapiro JA; Rybicki BA; Enger SM; Van Den Eeden SK; Richert-Boe KE; Weiss NS
    Cancer Causes Control; 2010 Jan; 21(1):117-25. PubMed ID: 19816779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan Public Health Center-based prospective study.
    Otani T; Iwasaki M; Yamamoto S; Sobue T; Hanaoka T; Inoue M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1492-500. PubMed ID: 14693743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of serum ferritin levels with the risk of stomach cancer.
    Nomura A; Chyou PH; Stemmermann GN
    Cancer Epidemiol Biomarkers Prev; 1992; 1(7):547-50. PubMed ID: 1302566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.